Optical coherence tomography imaging is playing a growing role in ophthalmology diagnosis, but it is lacking something that other established imaging modalities have: a consensus “phantom” eye model to bench test image quality, say FDA researchers.
The agency wants to collaborate with others to address that issue
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?